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Abstract
Background: The present study investigates the suitability of various treatment outcome indicators to evaluate
performance of mental health institutions that provide care to patients with severe mental illness. Several
categorical approaches are compared to a reference indicator (continuous outcome) using pretest-posttest data of
the Health of Nation Outcome Scales (HoNOS).
Methods: Data from 10 institutions and 3189 patients were used, comprising outcomes of the first year of
treatment by teams providing long-term care.
Results: Findings revealed differences between continuous indicators (standardized pre-post difference score ES
and ΔT) and categorical indicators (SEM, JTRCI, JTCS, JTRCI&CS, JTrevised) on their ranking of institutions, as well as
substantial differences among categorical indicators; the outcome according to the traditional JT approach was
most concordant with the continuous outcome indicators.
Conclusions: For research comparing group averages, a continuous outcome indicator such as ES or ΔT is
preferred, as this best preserves information from the original variable. Categorical outcomes can be used to
illustrate what is accomplished in clinical terms. For categorical outcome, the classical Jacobson-Truax approach is
preferred over the more complex method of Parabiaghi et al. with eight outcome categories. The latter may be
valuable in clinical practice as it allows for a more detailed characterization of individual patients.
Keywords: Clinical significance, HoNOS, Routine outcome monitoring, Severe mental illness, Treatment outcome
Background
Routine Outcome Monitoring (ROM) is gathering momen-
tum as an adjunct to treatment [1, 2] and as a basis for out-
come management [3]. In the Netherlands, ROM has been
stimulated by health insurers, resulting in a nationwide im-
plementation of ROM in clinical practice to serve both
goals: providing feedback on individual treatment progress
and on outcomes attained with groups of patients (aggre-
gated outcomes). The present paper focuses on the latter.
Currently about 45% of all remunerated treatments can be
evaluated, and results are aggregated and used to give
feedback to institutions on their performance in terms of
outcome [4]. For ROM assessments of patients with severe
mental illness (SMI), the Health of Nation Outcome Scales
(HoNOS) [5] is used, a well-known rating scale generally
completed by the professional who delivers care. The
HoNOS comprises 12 items, each with five response op-
tions (scoring range is 0–48), and has good psychometric
properties [6]. Outcome on clinical problems and psycho-
social functioning is assessed by comparing pretest and
posttest total scores on the HoNOS for each patient. The
simplest, most straightforward and most commonly used
outcome indicator in treatment outcome research is the
average change from pretest to posttest score, converted
into a standardized change score or within- group effect
size (ES) indicator [7, 8]. For benchmarking in the
Netherlands, we have adapted this approach to a change
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score based on transformed T-scores (ΔT) [9]. However,
average change offers rather abstract information on the
performance of treatment institutions. It would be inform-
ative to know what proportion of patients have benefitted
from treatment or can be considered as recovered, yielding
a performance indicator with direct appeal.
Jacobson et al. [10–12] have proposed a method to delin-
eate the treatment results of individual patients, comprising
criteria for clinically significant and statistically reliable
change. The outcome is deemed significant if a patient’s post-
test score is within the functional range; a patient has reliably
changed if the pretest-posttest change is larger than a chance
fluctuation due to instrument measurement error. Various
revisions of the Jacobson-Truax (JT) approach have been
proposed [13–15], finding extensive application in comparing
outcomes of groups of patients [16–18] as well as in ROM
for individual patients [19]. Recently we evaluated the
practicality of this approach as an indicator of institutional
performance, using pretest and posttest scores on self-report
measures. The JT approach was deemed a worthy addition
to traditional performance indicators such as pretest-posttest
ES or change in T-score (ΔT), as it illustrates these numerical
values in a clinically meaningful manner with children and
adolescents [20], and with adults with common mental
disorders such as depression and anxiety disorders [9].
Application of JT to rating scales, such as the HoNOS, is
less common than its application to self-report measures.
The results appear of limited use when the JT approach is
applied to HoNOS for the SMI population, as usually a very
large proportion of patients is deemed unchanged. This
may reflect the chronicity of SMI, where change – let alo-
ne(clinical) recovery or remission – is relatively uncommon
within the time frame of one or two years. It may be caused
by lack of responsiveness to change of the HoNOS, espe-
cially for patients with low pretest scores to begin with [21],
but it may also be due to the stringency of JT criteria, par-
ticularly for reliable change [22]. In a paper published in
2005, Parabiaghi et al. [23] proposed for the HoNOS total
score that a change of at least 8 points is required to deem
a patient as statistically reliably changed. Such a change in
score is substantial and infrequent in care provided to the
majority of patients with SMI, but is also a stringent criter-
ion when the HoNOS is applied to evaluate outpatient care
for common mental disorders [21]. Other values for reliable
change and alternative statistical approaches to arrive at
performance indicators for use with the HoNOS have been
proposed by Burgess et al. [24]. They discuss the merits of
effect size (ES), reliable change index (RCI), and standard
error of measurement (SEM), proposing various threshold
values for these indicators to distinguish unchanged from
changed patients (improved or deteriorated), varying in
statistical uncertainty. Utilization of each threshold score
yields three possible outcomes: no significant change, sig-
nificant improvement, and significant deterioration.
In order to obtain an improved categorization for use
with HoNOS data, in a more recent paper from 2014
Parabiaghi et al. [22] describe a revised approach to JT.
This approach (JTrevised) focuses more on outcome than
on change, underlining the significance of slightly changed
and unchanged subjects. Where JT distinguishes two clas-
ses of patients (dysfunctional and functional), Parabiaghi
et al. propose three classes of severity for the HoNOS total
score: mild (< 10), moderate (10–13), and severe (> 13).
They also propose two levels of meaningful change: reli-
ably changed (RCI 90%; at least 8 points) and minimally
changed (at least 4 points change). Potentially, the method
proposed by Parabiaghi et al. [22] is an improvement over
the traditional JT approach: as it allows for a more com-
prehensive categorization of treatment results, it seems
better suited to meet the demands of clinical reality.
In the present study, we compared several categorical
approaches as clinical illustrations of ES and ΔT: classifi-
cations into three categories (improved, unchanged, and
deteriorated) based on ES and RCI threshold values, di-
chotomous classifications (JTRCI and JTCS), the more
complex classification of JT into four categories (recov-
ered, improved, unchanged, deteriorated, or JTRCI&CS),
and the proposed revised JT of Parabiaghi et al. [22] into
eight categories (JTrevised). We evaluated which categorical
method is most suitable to denote outcome for patients
with SMI by comparing the ranking of institutions accord-
ing to ES and/or ΔT with their ranking based on categor-
ical outcomes. ES/ΔT was chosen as the reference
method, as this outcome indicator is appropriate given the
continuous nature of the data, and it is the most com-
monly used effect indicator to denote within-group effect
size in treatment outcome research [8]. We therefore ex-
amined which of the categorical methods revealed the lar-
gest differences in outcome between mental health
institutions, whether rankings based on continuous and
categorical methods were concordant and evaluated the
informative value of each method.
It is important to note that the aim of the present study
was to compare performance indicators for their ability to
assess differences in outcome of care among institutions.
Variation in outcome between providers enables us to
compare performance indicators. The aim was not to
compare the performance of the participating institutions
per se. Case mix differences and differences in complete-
ness of the data among institutions preclude firm conclu-
sions regarding their comparative performance. We
consequently choose to anonymize institutions. The
reader should take note of the fact that ranking of insti-
tutes does not necessarily reflect an order in the quality of
care provided; it is merely a reflection of differences in
outcome, which may well be due to case mix differences
or other factors affecting outcome, such as timing of as-
sessments, proficiency in use of the HoNOS, etc.
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Methods
Design and participants
This is an observational study, using data from real-life
patients in everyday clinical practice. Data were collected
from 10 integrated mental health institutions in the
Netherlands and pertain to first-year-of-care episodes
completed in 2013 and 2014. Participating institutions offer
a mix of inpatient and intensive outpatient treatments,
day-clinic treatment, and what is known as (Flexible) As-
sertive Community Treatment ((F)ACT). Patients receiving
short-term crisis intervention were excluded. Data were
collected as part of the treatment and anonymized before
analysis. Patients were informed about use of the data for
routine outcome monitoring [2], and Dutch law allows use
of these anonymized ROM data for research [25]. The Cen-
tral Committee on Medical Research (CCMO) approved
the use of anonymized data. The study included data from
N = 3189 patients. Institutions contributed between 199
and 505 cases (M = 318,9; SD = 106.7; see Table 1). Institu-
tions are given a number that represents their position in
the rank order from worst to best outcome according to ES
and ΔT (both rankings are almost identical; where ties
occur in one indicator, ranking of tied institutions is based
on the other indicator).
Instrument
Health of nation outcome scales (HoNOS)
The Health of Nation Outcome Scales (HoNOS) was de-
veloped in 1993 by the Research Unit of the Royal College
of Psychiatrists to evaluate clinical treatment outcome [5].
The HoNOS is a rating scale, to be administered by a
trained practitioner or research assistant. The instrument
is short and easy to complete, and it was designed for rou-
tine clinical work. Its use is widespread, as it is the prime
outcome measure for mental health care in the UK [6],
Australia [26], and New Zealand [27]. In the Netherlands,
use of the HoNOS is limited to patients with SMI, who re-
ceive “integrated care , i.e. support living, work, and social
relations in addition to psychiatric treatment” [25]. It con-
sists of 12 items that cover clinical problems and social
functioning. Each item is evaluated on a 5-point (0–4)
Likert scale, resulting in a total score ranging from 0 to
48. Response options vary for each item and are anchored
with a comprehensive description. Several studies have
evaluated the HoNOS and found support for its reliability,
validity, and sensitivity to change [25, 27, 28].
Methods for rendering treatment outcome
Continuous indicators (ES and ΔΤ)
A popular estimate of treatment outcome is the
within-group effect size estimator ES, denoting the size of
the pretest-posttest change in standardized units [8]. It pro-
vides a clear indication of what has been achieved in treat-
ment [29], and is calculated as the difference of pretest and
posttest scores divided by the pretest standard deviation of
the instrument for patients.
ΔT is an outcome indicator similar to ES, but based on
the difference between pretest and posttest scores trans-
formed to standardized T-scores [30] with a normal distribu-
tion of scores. Raw HoNOS scores are asymmetrical and
skewed to the right, which implies that intervals in the lower
scale range are not equal to intervals in the higher range.
Normalization turns the HoNOS into a true interval scale, a
measurement level required for subtraction [31]. T-scores
have a standard deviation of 10, therefore ΔT is similar to ES
but 10 times larger. For the present study, categorical indica-
tors based on raw scores were compared to ES, and categor-
ical indicators based on T-scores were compared to ΔT.
Table 1 Number of patients, gender, age, pretest-posttest response rate, and length of treatment (days) per institution
Institution 1 2 3 4 5 6 7 8 9 10 Total
Included N 1056 771 968 4754 2061 9221 2177 2076 1304 589 16,771
Assessed N 265 192 215 290 336 342 505 438a 407 199 3189
% 8.3 6.0 6.7 9.1 10.5 10.7 15.8 13.7 12.8 6.2 100.0
Response % 25.1 24.9 22.2 6.1 16.3 33.7 23.2 21.1 31.2 33.8 19.1
Length of M 337.7 328.9 326.8 284.1 312.4 314.0 288.6 294.8 225.6 329.9 297.9
treatment SD 51.8 57.4 54.6 99.2 73.2 80.5 91.8 85.8 138.9 41.8 93.5
Males N 164 121 130 238 170 227 282 155 248 123 1858
% 61.9 63.0 60.5 82.1 50.6 66.4 55.8 35.4 60.9 61.8 58.3
Age M 40.0 40.2 42.7 38.8 42.5 37.8 42.7 40.6 39.0 42.6 40.7
SD 12.4 12.8 11.5 10.6 11.6 13.0 12.3 11.9 12.4 13.8 12.3
HoNOS M 9.7 14.0 13.6 14.9 13.3 11.2 11.5 12.3 13.3 10.3 12.4
pretest SD 5.4 3.0 2.0 7.5 6.0 5.8 6.1 6.4 7.2 6.1 6.5
HoNOS M 9.4 12.1 12,8 13.8 11.5 9.5 9.6 9.8 10.5 7.9 10.5
posttest SD 6.4 6.8 7.0 6.9 5.9 5.8 6.0 6.2 6.8 5.8 6.5
aFor 112 (12.1%) of 438 patients of institution 8 no information on gender was provided
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Categorical indicators based on ES, RCI and RCI threshold
values
Burgess, Pirkis and Coombs [24] propose various thresh-
old values for ES, RCI, and SEM when using raw HoNOS
scores to classify patients as unchanged, improved or dete-
riorated. Significantly changed are patients with a change
of at least ESmedium = 4 or ESlarge = 6, four RCI thresholds
with different confidence levels (RCI95 = 10, RCI90 = 9;
RCI80 = 7 and RCI67 = 5), and a single threshold value
based on SEM proposed by McHorney and Tarlov [32].
SEM is calculated by multiplying the standard deviation
by the square root of 1 minus the reliability coefficient.
For the HoNOS when used with inpatients Burgess et al.
[24] propose SEM= 5.
Categorical indicators based on the JT approach
Traditional Jacobson-Truax (JTCS, JTRCI and
JTRCI&CS) JT is a widely accepted approach to denote
clinically significant change in patients and to identify
meaningful individual improvement [16]. Based on the
criteria described in the Introduction, JT yields three indi-
cators: (a) clinical significance composed of a cut-off point
where “the patient moves outside the dysfunctional popu-
lation or within functional population” (JTCS); (b) reliable
change index, which indicates whether the change that oc-
curred was statistically significant (JTRCI); and (c) the
combination of these two (JTRCI&CS), which categorizes
outcome of treatment into “deteriorated”, “unchanged”,
“improved” or “recovered” [11]. We applied the traditional
JT approach to raw scores (RCI = 8, CS = 5) [23] and to
transformed T-scores (RCI = 5 and CS = 42.5) [9, 20].
Revised JT model
Parabiaghi et al. [22] proposed a revised model of JT to de-
note meaningful clinical outcome for patients with SMI,
using two change and two endstate threshold values. First,
they proposed three levels of change: reliable change (RCI:
change ≥8), minimal change (based on the SEM: change
≥4), or no change or stability (change < 4). They also pro-
posed distinguishing three levels of severity: mild (HoNOS
score < 10), moderate (score = 10–13), and severe (score >
13). All in all, this combination of two change criteria and
two severity cut-offs leads to a complex “research model”
comprising 23 outcome categories (see Parabiaghi et al.
[22]; Fig. 1, p. 299). For clinical use they propose a simpli-
fied version using a single change criterion (at least 4 points
change, the more lenient criterion for a minimally detect-
able change based on SEM; the chosen value of 4 is based
on data of Italian and Dutch patients) and the two CS
values (10 and 13). Combination of three possible outcomes
according to SEM-based minimally detectable change (im-
proved, unchanged, or worsened) and three severity levels
(mild, moderate, and severe) results in a categorization into
nine groups (see Parabiaghi et al. [22]; Fig. 2, p. 300). Stable
patients are categorized into three levels: “stability in mild
illness”, “stability in moderate illness”, and “stability within
severe illness”, utilizing the cut-off values of 10 and 13 on
the means of their pretest and posttest HoNOS scores.
Based on the posttest HoNOS score, three improved
groups are distinguished: “improved to mild illness”, “im-
proved to moderate illness”, and “improved within severe
illness”. As worsening to a mild level is a relatively rare
event, those who showed significant worsening from pretest
to posttest were allocated to only two categories: “worsen-
ing to mild or moderate illness” and “worsening to severe
illness”, using the cut-off value of 13 to distinguish between
the two groups [22]. Hence the simplified JTrevised model
results in eight outcome categories (see Table 5).
Statistical analysis
Outcomes between institutions were compared and the
ability of the various indicators to distinguish between
them was investigated. A repeated-measures ANOVA for
a 2 (time) × 10 (institution) design was conducted on
transformed T-scores to test for main effects of time and
institution as well as for their interaction to compare out-
come slopes of institutions over time. Post hoc pairwise
comparisons were conducted to assess which institutions
differed from each other. For the categorical outcomes we
assessed the differences in proportions with chi-squared
tests. Ranking of institutes according to each outcome in-
dicator is presented and compared to ranking according
to ES or ΔT (the reference indicator for raw scores or
T-scores, respectively). Concordance between rankings is
assessed with the Spearman Rank correlation coefficient.
Results
The initial dataset comprised 16,771 patients who received
treatment; 8402 (50.1%) were assessed at pretest and for
38.0% of these posttest data were available, yielding a final
sample of 3189 patients with complete pretest and post-
test data and an overall response rate of 19.1%. Table 1
presents background information on the participating pa-
tients. The duration of care episodes ranged from 30 to
446 days (M= 297.8; SD = 93.4), with no significant differ-
ences between institutions. Pretest selection, posttest attri-
tion and overall response rates (the proportion of care
episodes with complete pretest and posttest data) varied
considerably between institutions (range: 6.1–33.8%).
There were statistically significant, albeit small, differ-
ences between institutions in mean age and gender; over-
all 58.3% of patients were males and gender was unevenly
distributed among the 10 institutions (χ2(9) = 103.44;
p < .001), with Institution 4 treating more males (82.1% vs.
58.3% for the total population). Participants’ age ranged
from 17 to 84 years (M = 40.7; SD = 12.3) and varied
among institutions (F(9) = 7.34; p < .001; η2 = .02), with
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Institutions 4, 6, and 9 treating somewhat younger pa-
tients. The mean pretest score on the HoNOS differed sig-
nificantly between institutions (F(9) = 18.04; p < .001;
η2 = .05), with Institutions 1, 6, and 10 having lower scores
(i.e. less impairment in function) than the others accord-
ing to Bonferroni corrected pairwise comparisons.
There were large differences in diagnostic composition
of the case mix among institutions. Table 2 presents this
diagnostic information. The largest group among the diag-
noses is psychotic disorders (47.3%), followed by mood/
anxiety/somatoform disorders (17.9%) and personality dis-
orders (11.4%). The smallest groups are pervasive develop-
mental disorders (10.5%), substance abuse (5.0%), and
bipolar disorder (4.9%). Patient composition differs signifi-
cantly among institutions (χ2(54) = 1583.09; p < .001), with
Institution 4 treating more patients with substance-related
disorders (36.9%) and fewer psychotic disorders (13.4%),
Institution 5 treating more patients with mood/anxiety/
somatoform disorders (36.0%) and fewer personality
disorders (18.8%), Institution 6 treating more patients with
pervasive developmental disorders (44.7%), and Institu-
tions 8, 5, and 1 treating more personality disorders (19.4,
18.8 and 17.7%, respectively).
Difference between pretest-posttest change on HoNOS
T-scores among institutions was analyzed in a 2 (time) × 10
(institution) repeated-measures ANOVA. This revealed sta-
tistically significant main effects of time (F(1) = 233.4;
p < .001; η2 = .068) and institution (F(9) = 23.6; p < .001;
η2 = .063), which reflects a difference over time as well as
between institutions regardless of time. More importantly,
there was a significant interaction effect (time x institution)
revealing a difference in outcome slope between health
institutions over time (F(9,3179) = 3.33; p < .001; η2 = .009).
Pairwise comparisons of institutions (with Bonferroni cor-
rection) revealed that Institutions 5 to 10 reported larger
pretest-posttest differences than Institutions 1 to 4.
Ranking of institutions was based on ES and ΔT. Hence,
institutions with a higher rank number have a larger ES
than those with a low rank number, as Table 3 shows. This
table also presents results using threshold values for ES,
SEM, and JTRCI90. All categorizations reveal significant dif-
ferences among institutions (all p < .001). The proportions
of reliably changed patients from Table 3 using the RCI
threshold of at least 8 points as proposed by Parabiaghi
et al. [23] varied among institutions (χ2(9) = 58.1; p < .001),
as did the proportions of patients with a posttest score < 5,
denoting a clinically significant change (χ2(9) = 42.8; p
< .001). Finally, combining both indices in four outcome
categories also reveals differences among institutions
(χ2(27) = 111.4; p < .001). Institutions with a higher rank
number had more recovered (= Institution 9: 17.4% vs. =
Institution 1: 4.9%) and fewer deteriorated patients (= Insti-
tution 9: 10.6% vs. Institution 6: = 3.8%). The results indi-
cate that 11.2% (n = 356) of patients had recovered, 6.1%
(n = 196) had improved, 75.9% (n = 2421) remained un-
changed, and 6.7% (n = 215) had deteriorated. The large
proportion of unchanged patients results from the stringent
RCI criterion of at least 8 points change. The ranking of in-
stitutes diverges considerably among indicators, and most
indicators have no statistically significant association with
ES, except for the improved and reliable change (JTRCI) in-
dicators, which correspond best with ES. All in all, most of
the indicators proposed by Burgess et al. [24] and JTRCI&CS
based on raw scores are insufficiently concordant with ES.
Table 2 Overview of the case mix composition regarding main psychiatric diagnosis per institution
Institution 1 2 3 4 5 6 7 8 9 10 Total
Psych. Dis. N 132 128 127 39 108 108 282 195 264 125 1508
% 49.8 66.7 59.1 13.4 32.1 31.6 55.8 44.5 64.9 62.8 47.3
MAS N 27 23 25 61 121 29 110 80 64 31 571
% 10.2 12.0 11.6 21.0 36.0 8.5 21.8 18.3 15.7 15.6 17.9
Pers. Dis. N 47 11 21 38 63 28 37 85 21 12 363
% 17.7 5.7 9.8 13.1 18.8 8.2 7.3 19.4 5.2 6.0 11.4
Perv. DD N 32 20 14 36 17 153 29 15 11 9 336
% 12.1 10.4 6.5 12.4 5.1 44.7 5.7 3.4 2.7 4.5 10.5
Bipolar Dis. N 18 5 7 4 14 17 12 23 38 18 156
% 6.8 2.6 3.3 1.4 4.2 5.0 2.4 5.3 9.3 9.0 4.9
Substance N 4 2 17 107 6 4 5 12 0 1 158
% 1.5 1.0 7.9 36.9 1.8 1.2 1.0 2.7 0.0 0.5 5.0
Other N 5 3 4 5 7 3 30 28 9 3 97
% 1.9 1.6 1.9 1.7 2.1 0.9 5.9 6.4 2.2 1.5 3.0
Psych. Dis. Psychotic Disorders, MAS Mood, anxiety, and somatoform disorders, Pers. Dis. Personality Disorders, Perv. DD Pervasive Developmental Disorders, Bipolar
Dis. Bipolar Disorders, Substance Substance Abuse
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Table 4 presents the results when we convert the
HoNOS scores to T-scores. Again, institutions with a high
rank number performed better (ΔT = range 3.3–4.3) than
those with a lower rank number (ΔT range 0.9–3.0). Using
the threshold of a change ΔT > 5 [9, 20], the proportions
of reliably changed patients differed significantly among
institutions (χ2(9) = 29.8; p < .001), as did the proportions
of patients transgressing the threshold of CS = 42.5 (pre-
test ≥42.5; posttest < 42.5), denoting clinically significant
change (χ2(9) = 30.4; p < .001). Combining the two indices
into JTRCI&CS with four categories also reveals significant
differences among institutions (χ2(27) = 76.1; p < .001).
Furthermore, with the traditional JTRCI&CS method ap-
plied to T-scores, patients got more evenly distributed
over the outcome categories: in total 18.8% (n = 598) of
patients were considered recovered, 22.2% (n = 709) had
improved, 40.0% (n = 1277) remained unchanged, and
19.0% (n = 605) had deteriorated. Institutions with a
higher rank have more recovered patients (Institution 10:
24.6% vs. = Institution 1: 12.5%) and fewer deteriorated
Table 3 Effect Size (ES) and percentage of patients in outcome categories based on raw HoNOS scores and classification according
to various ESmedium, SEM, and JTRCI-90 threshold values, and according to JTRCI95, JTCS, and JTRCI&CS
Institution 1 2 3 4 5 6 7 8 9 10 Total Rank ordera Rho
Continuous: ES 0.06 0.18 0.19 0.24 0.29 0.29 0.32 0.38 0.38 0.39 0.29 1 2 3 4 5/6 7 8/9 10
Categorical:
ESmedium ≤ −4 deteriorated 20.0 19.3 20.5 20.7 15.2 11.4 17.8 14.8 20.9 14.1 17.3 9 4 3 1 2 7 5 8 10 6 .35
-4 < ESmedium < 4 unchanged 56.2 48.4 43.7 40.0 49.7 57.6 45.0 42.7 34.4 46.7 45.9 6 1 5 2 10 7 3 8 4 9 .38
ESmedium ≥ 4 improved 23.8 32.3 35.8 39.3 35.1 31.0 37.2 42.5 44.7 39.2 36.8 1 5 2 8 4 3 6 9 10 7 .71*
SEM≤ −5 deteriorated 15.5 13.0 15.3 17.6 12.5 9.1 14.5 11.0 16.2 11.1 13.5 4 9 1 3 7 2 5 10 8 6 .35
-5 < SEM < 5 unchanged 63.4 60.4 56.3 49.3 57.1 68.1 53.7 52.7 45.9 54.8 55.5 6 1 2 5 3 10 7 8 4 9 .55
SEM≥ 5 improved 21.1 26.6 28.4 33.1 30.4 22.8 31.9 36.3 37.8 34.2 30.9 1 6 2 3 5 7 4 10 8 9 .79**
JTRCI90 ≤ −9 deteriorated 8.3 4.2 7.0 9.3 3.6 2.3 5.1 3.9 7.6 2.5 5.4 4 1 9 3 7 2 8 5 10 6 .43
9 < JTRCI90 < 9 unchanged 85.3 82.8 80.0 71.4 87.5 88.0 82.2 79.2 69.0 83.9 80.6 6 5 1 10 2 7 3 8 4 9 .24
JTRCI90 ≥ 9 improved 6.4 13.0 13.0 19.3 8.9 9.6 12.7 16.9 23.3 13.6 14.1 1 5 6 7 2/3 10 8 4 9 .51
JTRCI (change ≥8) reliable change 9.4 14.6 14.9 19.7 11.3 14.3 17.4 21.7 27.0 15.6 17.3 1 5 6 2 3 10 7 4 8 9 .64*
JTCS (post < 5) clinical change 13.6 9.9 7.0 7.2 8.6 14.9 16.0 15.5 15.2 21.1 13.3 3 4 5 2 10 1 6 8 7 9 .56
JTRCI&CS deteriorated 9.1 5.2 8.4 10.3 3.9 3.8 5.9 5.7 10.6 4.5 6.7 9 4 1 3 7 8 2 10 5 6 .14
unchanged 81.5 80.2 76.7 70.0 84.8 81.9 76.6 72.6 62.4 79.9 75.9 5 6 1 2 10 3 7 8 4 9 .39
improved 4.5 4.7 3.3 4.1 3.0 6.1 6.3 8.7 9.6 8.0 6.1 5 3 4 1 2 6 7 10 8 9 .75*
recovered 4.9 9.9 11.6 15.5 8.3 8.2 11.1 13.0 17.4 7.5 11.2 1 10 6 5 2 7 3 8 4 9 .24




; JTRCI ¼ Mpretest−MposttestSEM ; JTCS ¼ SDpreMpostþSDpostMpreSDpreþSDpost
ESmedium implies a change of at least 4 points; SEM implies 5 points change or more; JTRCI90 implies 9 points change; JTRCI90, JTCS, and JTRCI&CS imply 8 points
change and transgression of a score of 5 from pretest to posttest. Rho is Spearman rank correlation coefficient between the ranking based on an indicator and
ranking based on ES (*p < .05; **p < .01)
aRanked from the worst (1) to the best (10) outcome according to the indicator; categories “unchanged” and “deteriorated” have a reversed rank order: the fewer
the patients the better the outcome
Table 4 Mean ΔT and percentage of patients in outcome categories based on T-scores according to the JT approach
Institution 1 2 3 4 5 6 7 8 9 10 Total Rank ordera Rho
Continuous: Mean ΔT 0.9 2.0 2.0 2.6 2.8 3.0 3.3 4.1 4.3 4.3 3.1 1 2/3 4 5 6 7 8 9/10
Categorical:
JTRCI-95 (> 5) improved 33.6 34.4 37.7 40.0 37.5 36.5 43.0 46.8 46.9 45.7 41.0 1 2 6 5 3 4 7 10 8 9 .86**
JTCS (42.5) changed 14.0 14.1 19.1 14.8 17.6 20.5 23.6 23.1 23.8 25.6 20.2 1 2 4 5 3 6 8 7 9 10 .95**
JTRCI&CS deteriorated 23.4 18.2 21.4 22.1 16.1 14.3 20.2 16.0 21.9 17.1 19.0 1 4 9 3 7 2 10 5 8 6 .38
unchanged 43.0 47.4 40.9 37.9 46.4 49.1 36.8 37.2 31.2 37.2 40.0 6 2 5 1 3 4 8/10 7 9 .65*
improved 21.1 21.4 19.1 26.9 22.0 18.7 21.4 24.9 23.6 21.1 22.2 6 3 1 10 2/7 5 9 8 4 .26
recovered 12.5 13.0 18.6 13.1 15.5 17.8 21.6 21.9 23.3 24.6 18.8 1 2 4 5 6 3 7 8 9 10 .93**
aInstitutions are rank ordered according to increased performance (the higher the rank number the more improved or recovered patients); categories
“unchanged” and “deteriorated” have a reversed rank order (fewer patients means a higher rank and a better outcome)
*p < .05; **p < .01
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patients (Institution 10: 17.1% vs. = Institution 1: 23.4%).
The Rho correlation coefficients indicate that the rankings
based on ΔT scores (in Table 4) are more concordant than
rankings based on raw HoNOS difference scores (ES in
Table 3), with JTRCI&CS recovery having the highest con-
cordance with ΔT, followed by the category of unchanged
patients. However, lack of concordance is also noteworthy.
Institution 9, for instance, has the second-highest ranking
based on ΔT, but also the third-largest proportion of dete-
riorated patients (based on JTRCI&CS; see Table 4).
The results of Table 5 show the categorization according
to the revised JT proposed by Parabiaghi et al. (2014). A
significant difference among institutions in these categor-
ies is found, with higher rates of patients in the “mild ill-
ness” and “improvement to mild illness” categories and
lower rates of “stability in severe illness” or “worsening in/
to severe illness” among institutions with a high ranking
(χ2(63) = 230.9; p < .001). Correspondence between rank-
ing of institutes according to ES and the JTrevised
categorization is low, except for the category “improve-
ment to mild illness”.
Discussion
In the present study, we compared various categorical indi-
cators on their usefulness to illustrate differences between
institutions regarding treatment outcome. The primary aim
of the study was to test the suitability of various categorical
methods to denote treatment outcome in mental health
care for patients with SMI using the HoNOS as assessment
instrument. We were fortunate to find differences in out-
comes between institutions and could use their data to
evaluate various methods to delineate outcome. We also
assessed the suitability of a number of methods to compare
institutions. The results revealed differences in ranking in-
stitutions between the two continuous indicators (ES and
ΔT) and the categorical indicators (SEM, JTRCI, JTCS,
JTRCI&CS, JTrevised). Indicators based on categorical
outcomes yielded quite divergent rankings; the categories
of the traditional JT approach were most concordant with
the continuous outcome indicators ES and ΔT, particularly
JTRCI and JTCS based on T-scores.
The traditional JT approach (JTRCI&CS) with four cat-
egories is applied frequently in practice and provides use-
ful information on patients’ condition after treatment [9,
11, 16]. However, as an outcome indicator for aggregated
data it has some serious drawbacks. As the indicator clas-
sifies patients into four categories, it is impossible to rank
health institutions consistently: ranking according to pro-
portion of recovered patients yields a different order than
ranking according to proportion of reliably changed pa-
tients, and so forth. A possible solution would be to col-
lapse the four categories into two, in order to get a
ranking based on less complex information, but this re-
duces information value and statistical power. Fedorov,
Mannino and Zhang [33] calculated that dichotomizing
information leads to a substantial loss of statistical power
(at least 36% reduction when data are made binary and
19% when data are converted to three categories). These
percentages are based on optimal cut-off points. In prac-
tice, the loss of statistical power may be greater. Indeed,
Markon, Chmielewski and Miller [34] showed that a sam-
ple needed to be twice as large when moving from a con-
tinuous to a dichotomous outcome. Statistical power can
be increased by adding more categories, but this reintro-
duces the complexity of interpreting the outcome data.
Another drawback of the JTRCI&CS method is that it will
result in a large proportion of “unchanged” patients if a
stringent criterion for RCI ≥ 8 is applied to raw HoNOS
scores. Such a large category provides little information
and is hard to interpret, as we are unsure whether to re-
gard this outcome as disappointing or as successful
stabilization (this of course also depends on the goal of
treatment or care). Using various alternative cut-off values
for deterioration or improvement, as proposed by Burgess
Table 5 Percentage of subjects classified into 8 outcome categories based on raw scores according to the revised JT approach of
Parabiaghi et al. [22]
institution 1 2 3 4 5 6 7 8 9 10 Total Rank ordera Rho
Mild illness 40.4 17.7 21.4 15.2 22.9 36.3 29.3 24.9 21.1 34.2 26.4 4 2 9 3 5 8 7 10 6 1 .13
Improvement to mild illness 18.5 17.7 22.3 18.3 20.5 22.8 26.9 28.3 31.2 32.7 24.6 2 4 1 5 3 6 7 8 9 10 .92**
Improvement to moderate illness 3.8 6.8 7.0 11.4 7.7 4.4 6.9 8.2 7.1 4.5 6.9 1 6 10 2 7 3 9 5 8 4 .23
Improvement within severe illness 1.5 7.8 6.5 9.7 6.8 3.8 3.4 5.9 6.4 2.0 5.3 1 10 7 6 8 9 3 5 2 4 −.29
Stability in moderate illness 12.1 12.0 8.4 9.3 10.4 11.4 9.1 7.8 5.9 8.0 9.2
Worsening to moderate illness 4.9 5.2 3.3 2.8 2.7 2.0 4.0 3.9 4.4 3.0 3.6 2 1 9 7 8 3 10 4 5 6 .26
Stability in severe illness 7.2 20.3 15.8 17.9 18.8 11.7 8.9 11.4 10.3 8.0 12.5
Worsening in/to severe illness 11.7 12.5 15.3 15.5 10.1 7.6 11.5 9.6 13.5 7.5 11.4 4 3 9 2 1 7 5 8 6 10 .52
Improvement based on SEM: pre-to-posttest change ≤4
Mild illness: post < 10; moderate illness: post = 10–13; severe illness post > 13
aRank order is not provided for stability categories; rank order of worsening is reversed
**p < .01
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et al. [24], does not lead to a categorization highly con-
cordant with ES. The present results show that applying
the JT categorization after raw scores have been converted
into transformed T-scores yields a more even distribution
of patients over the outcome categories. Moreover, ranking
of institutes according to proportion of recovered patients
based on transformed T-scores is more concordant with
outcome according to ΔT than the ranking using raw
scores. We therefore recommend using transformed
T-scores with the proposed cut-off values RCI > 5 and CS
= 42.5 – corresponding to RCI > 2 to RCI > 4 (depending
on the position on the scale) and CS = 8 in raw score on
the HoNOS – as the most suitable approach to convey dif-
ferences in performance between institutions, given that
this indicator is methodologically sound as it uses data that
have been transformed into a normal distribution.
Parabiaghi et al. [22] evaluated a more refined approach
for meaningful change and outcome. We examined this ap-
proach and compared it with the traditional JT approach,
to investigate how these categorical methods compare in
their convergence with the continuous method and how
they compare in denoting outcome in a meaningful way.
The results indicate that the proposed revision may have
advantages over the traditional JT approach, as it provides a
quite meticulous and clinically meaningful way to denote
clinical status and outcome of care for individual patients
with SMI. JTrevised may thus be more informative for
clinicians when monitoring progress and choosing the most
appropriate course of treatment as compared to the trad-
itional JT approach. Further validation of JTrevised is needed
to justify use of its more refined outcome categories. It
should also be noted that the threshold value for change
based on SEM (change ≥4 is deemed meaningful) needs
validation, as it is far more lenient than the RCI90 ≥ 9 based
on the formulas proposed by Jacobson and Truax and the
reliability of the HoNOS may not justify the chosen
low-threshold value. Future research, for instance directly
comparing the predictive validity of the categorization ac-
cording to the traditional JT approach and the JTrevised in
terms of further course of treatment, will reveal which ap-
proach best predicts need for care after the first year. How-
ever, the Parabiaghi approach is deemed too complex for
research on groups of patients or for use as a performance
indicator comparing aggregated outcomes of institutions:
with eight categories it is not considered a practical or more
appropriate alternative to the simpler traditional JTRCI&CS
with four categories.
A strength of the present study is its use of real-life data,
collected in everyday clinical practice. The study also uses
a considerably large data set, in number of both institu-
tions and patients per institution, boosting confidence in
the generalizability of the findings for clinical practice in
the Netherlands and bringing about ample statistical
power to find differences among methods to denote
outcome. Indeed, substantial variation in outcome was
found among institutions, offering a realistic test of the
usefulness of various approaches to denote outcome of
patients in care for SMI.
A limitation of the study is that only data from the first
year of care were analyzed. Patients with SMI typically stay
in care for a longer period. Their change in subsequent
years of care is likely to be substantially smaller, as may also
be the case for outcome variation between institutions. It
should be noted that the substantial differences between in-
stitutions in case mix composition for demographics and
clinical features of patients, as well as differences in com-
pleteness of provided data, imply that outcomes of institu-
tions are potentially confounded by these pretest
differences. For example, institutions’ patient populations
vary in pretest severity, a variable strongly associated with
posttest scores and gain scores; this implies that the level of
pretest severity is also associated with categorical outcomes.
Higher average pretest levels leave more room for reliable
improvement, lower pretest levels leave less room but make
achieving recovery status more likely. In addition, case mix
composition between institutions also differed in ratio of
inpatients to community patients. This underscores the
need for case mix correction when comparing institutional
performance. We reanalyzed the data after case mix correc-
tion for several variables that appeared associated with out-
come (pretest severity, age, and bipolar disorder). This case
mix model explained 23% of outcome variation (predomin-
antly by pretest HoNOS scores). Correction did influence
average outcome of institutions, but overall the ranking of
institutes remained the same. However, differences between
institutions diminished somewhat, and with this smaller
contrast between institutions the rankings of the various
approaches were more diverse. Consequently, the concord-
ance between approaches was also more varied. As a fur-
ther limitation of the study, response rates for institutions
ranged from 6.1 to 33.8%, compromising the representa-
tiveness of the data for the institutions. Hence, the present
results do not necessarily reflect differences in quality of
care between institutions and should be examined cau-
tiously, also bearing in mind that comparing institutions
was not our aim. Moreover, the overall response rate limits
the generalizability of the study findings, as we do not know
whether outcome data are missing systematically.
The HoNOS total score may be considered too small a
basis to evaluate the outcome of an individual patient or
appraise the overall performance of mental health insti-
tutions. Use of the HoNOS is widespread, not only for
outcome monitoring but also to assign patients to clus-
ters based on their treatment needs. Large datasets have
thus become available to evaluate the psychometric
quality of the instrument, and some negative findings
have emerged. For instance, the HoNOS appears not to
be associated with need-for-care as operationalized by
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costs of treatment in a large British cohort of 1343 pa-
tients with common mental health problems [35]. For
this patient group, the sensitivity to change in severity of
psychopathology of the HoNOS appears to be limited as
only three items (7, 8, and 9) seem relevant and appro-
priate [21]. The utility of the HoNOS for clustering pa-
tients into groups of various need levels has been
questioned as well [36]. Finally, the factorial structure of
the HoNOS has been criticized: the HoNOS does not
appear to be unidimensional, which casts doubt on the
validity of calculating a total score. Various multidimen-
sional factorial models have been proposed, but none ap-
pears to have sufficient fit to be deemed good over the
full range of psychiatric disorders [37]. Further develop-
ment of measurement instruments for appropriate out-
come domains (assessing severity of symptomatology,
functioning, and personal recovery) is therefore needed,
and several such projects are currently underway, inter-
nationally as well as in the Netherlands. Finally, the
present study lacks an external criterion to validate the
various methods to denote outcome. Additional infor-
mation on patients’ posttreatment functioning is needed,
such as continued use of mental health care after the
first year of treatment or long-term follow-up data (e.g.
several years after treatment has ended).
Conclusions
Methods based on continuous variables – ES on raw scores
or ΔT based on transformed T-scores – are the most con-
venient choice for research or for comparing institutions,
subdivisions or teams: they have the best statistical power
and allow for a straightforward ranking of institutions.
Based on this study, we conclude that the use of categorical
approaches is complicated as it matters importantly which
outcome category is considered for ranking institutions on
their performance. However, information from categorical
approaches is of supplemental value, as this illustrates what
differences in rank order mean in clinically relevant terms
and reveals what has been accomplished in clinically mean-
ingful terms. We recommend the traditional JT approach
as a good choice among the categorical indicators. The
revision by Parabiaghi et al. [22] provides more detailed
information, but eight outcome categories may be too
complex for a practical comparison of institutions.
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